Manchester Management
Vermillion Shareholder Alleges Medicare Denying Over 80 Percent of OVA1 Reimbursement Claims
Premium
This story originally ran on Dec. 22.
By Adam Bonislawski
Manchester Management Accuses Vermillion of Changing Meeting Date to Discourage Shareholder Action
Premium
Manchester Management's James Besser this week sent a letter to the company's board and shareholders asserting that management had moved the date of Vermillion's annual meeting to make difficult any action by shareholders dissatisfied by the poor performance of the firm's stock.
Citing Falling Share Price, Manchester Management Calls for Changes to Vermillion Leadership
Premium
An exchange this week between Vermillion and the Boston-based hedge fund that holds a nearly 10 percent stake in the company has exposed a rift between the company's management and one of its largest shareholders.
Manchester Management Seeks Changes at Vermillion to Protect Shareholder Value
The shareholder wants to make it easier to make changes to Vermillion's management team and board amid a drop in the company's share price over the past year.